Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation Study.

Autor: Kort S; Department of Respiratory Medicine, Medisch Spectrum Twente Enschede, Enschede, The Netherlands. Electronic address: s.kort@mst.nl., Brusse-Keizer M; Medical School Twente, Enschede, The Netherlands; Universiteit of Twente, Faculty of Behavioural Management and Social Sciences, Enschede, The Netherlands., Schouwink H; Department of Respiratory Medicine, Medisch Spectrum Twente Enschede, Enschede, The Netherlands., Citgez E; Department of Respiratory Medicine, Medisch Spectrum Twente Enschede, Enschede, The Netherlands., de Jongh FH; Department of Respiratory Medicine, Medisch Spectrum Twente Enschede, Enschede, The Netherlands; Universiteit of Twente, Faculty of Behavioural Management and Social Sciences, Enschede, The Netherlands., van Putten JWG; Department of Respiratory Medicine, Martini Ziekenhuis, Groningen, The Netherlands., van den Borne B; Department of Respiratory Medicine, Catharina Ziekenhuis, Eindhoven, The Netherlands., Kastelijn EA; Department of Respiratory Medicine, Sint Antonius Ziekenhuis, Utrecht, The Netherlands., Stolz D; Clinic for Pulmonary Medicine and Respiratory Cell Research, Universitätspital Basel, Basel, Switzerland; Clinic for Respiratory Medicine, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany., Schuurbiers M; Department of Respiratory Medicine, Radboud UMC, Nijmegen, The Netherlands., van den Heuvel MM; Department of Respiratory Medicine, Radboud UMC, Nijmegen, The Netherlands., van Geffen WH; Department of Respiratory Medicine, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands., van der Palen J; Medical School Twente, Enschede, The Netherlands; Universiteit of Twente, Faculty of Behavioural Management and Social Sciences, Enschede, The Netherlands.

Publikováno v: Chest [Chest] 2023 Mar; Vol. 163 (3), pp. 697-706. Date of Electronic Publication: 2022 Oct 13.

Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium.

Autor: de Joode K; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Tol J; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Hamberg P; Department of Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., Cloos M; Department of Internal Medicine, Groene Hart Hospital, Gouda, the Netherlands., Kastelijn EA; Department of Pulmonology, St. Antonius Hospital Utrecht/Nieuwegein, Utrecht, the Netherlands., Borgers JSW; Department of Medical Oncology, Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Nuij VJAA; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Klaver Y; Department of Internal Medicine, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands., Herder GJM; Department of Pulmonary Medicine, Meander Medical Center, Amersfoort, the Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Dumoulin DW; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., van Diemen NGJ; Department of Internal Medicine, Bernhoven, Uden, the Netherlands., Libourel EJ; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands., Geraedts EJ; Department of Pulmonology, Groene Hart Hospital, Gouda, the Netherlands., Bootsma GP; Department of Pulmonology, Zuyderland Medical Center, Heerlen, the Netherlands., van der Leest CH; Department of Pulmonology, Amphia Hospital, Breda, the Netherlands., Peerdeman AL; Department of Internal Medicine, Bernhoven, Uden, the Netherlands., Herbschleb KH; Department of Internal Medicine, St. Antonius Hospital Utrecht/Nieuwegein, Utrecht, the Netherlands., Visser OJ; Department of Hematology, Isala Hospital, Zwolle, the Netherlands., Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hendriks LEL; Department of Pulmonary Diseases GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands., Beerepoot LV; Department of Internal Medicine, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., van den Berkmortel FWPJ; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Dingemans AC; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., van der Veldt AAM; Department of Medical Oncology and Department of Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands. Electronic address: a.vanderveldt@erasmusmc.nl.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jan; Vol. 160, pp. 261-272. Date of Electronic Publication: 2021 Oct 25.

Prediction of Microscopic Metastases in Patients with Metachronous Oligo-Metastases after Curative Treatment of Non-Small Cell Lung Cancer: A Microsimulation Study.

Autor: Wolff HB; Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC, Location VUmc, 1081 HV Amsterdam, The Netherlands., Alberts L; Department of Pulmonology, St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands., Kastelijn EA; Department of Pulmonology, St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands., Verstegen NE; Department of Radiation Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., El Sharouni SY; Department of Radiation Oncology, University Medical Centre Utrecht, 3584 CX Utrecht, The Netherlands., Schramel FMNH; Department of Pulmonology, St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands., Vos R; Department of Methodology & Statistics, Maastricht University Medical Centre, 6200 MD Maastricht, The Netherlands., Coupé VMH; Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC, Location VUmc, 1081 HV Amsterdam, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2021 Apr 14; Vol. 13 (8). Date of Electronic Publication: 2021 Apr 14.

Cost-Effectiveness of Surveillance Scanning Strategies after Curative Treatment of Non-Small-Cell Lung Cancer.

Autor: Wolff HB; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, North Holland, The Netherlands., Alberts L; Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands., Kastelijn EA; Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands., El Sharouni SY; Department of Radiotherapy, University Medical Centre Utrecht, Utrecht, The Netherlands., Schramel FMNH; Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands., Coupé VMH; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, North Holland, The Netherlands.

Publikováno v: Medical decision making : an international journal of the Society for Medical Decision Making [Med Decis Making] 2021 Feb; Vol. 41 (2), pp. 153-164. Date of Electronic Publication: 2020 Dec 15.

Cost-effectiveness of stereotactic body radiation therapy versus video assisted thoracic surgery in medically operable stage I non-small cell lung cancer: A modeling study.

Autor: Wolff HB; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, the Netherlands. Electronic address: h.wolff@amsterdamumc.nl., Alberts L; Department of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands., van der Linden N; Department of Health Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, the Netherlands., Bongers ML; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, the Netherlands., Verstegen NE; Department of Radiation Oncology, Amsterdam UMC, Amsterdam, the Netherlands., Lagerwaard FJ; Department of Radiation Oncology, Amsterdam UMC, Amsterdam, the Netherlands., Hofman FN; Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands., Uyl-de Groot CA; Department of Health Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, the Netherlands; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, the Netherlands., Senan S; Department of Radiation Oncology, Amsterdam UMC, Amsterdam, the Netherlands., El Sharouni SY; Department of Radiotherapy, University Medical Centre Utrecht, Utrecht, the Netherlands., Kastelijn EA; Department of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands., Schramel FMNH; Department of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands., Coupé VMH; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, the Netherlands.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2020 Mar; Vol. 141, pp. 89-96. Date of Electronic Publication: 2020 Jan 16.